#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis respiratory infection suppression Arrhythmia Gastroenteropancreatic neuroendocrine tumour disease Mantle cell lymphoma stage II Metastatic malignant melanoma Bronchiectasis Small intestine adenocarcinoma Anal cancer recurrent Liver abscess Desmoplastic small round cell tumour Carcinoid syndrome Non-renal cell carcinoma of kidney Allogenic stem cell transplantation Osteosarcoma Glomerulonephritis membranoproliferative More trials…

    Learn about Rare Diseases

    Osteosarcoma Focal segmental glomerulosclerosis – Life with Disease Nephroblastoma – Diagnostics Systemic mastocytosis – Treatment Basal cell naevus syndrome Hairy cell leukaemia Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Haemophilia A without inhibitors – Diagnostics Gaucher’s disease type I – Life with Disease Alport’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Darolutamide Elenestinib Phosphate Perindopril Arginine Siponimod Fumaric Acid Batoprotafib Demeclocycline Hydrochloride Anhydrous Caffeine Streptococcus Agalactiae SODIUM SULFIDE NONAHYDRATE Encaleret Sulfate Namilumab Pertuzumab Fluoroethyltyrosine F-18 Sabatolimab Ubiquinol HYALURONIDASE Cevostamab ALXN1920 HYDROGEN Bemnifosbuvir Hemisulfate More therapies…

    Learn about Your Condition

    Hypogonadism male Periarthritis Peritoneal neoplasm Basal cell carcinoma Drug eruption Neuropathy peripheral Pyrexia Micrographic skin surgery Dyspnoea Blood iron increased Lymphangioleiomyomatosis High-grade B-cell lymphoma Retinal artery occlusion Gallbladder cancer Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Malignant melanoma

  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Oesophageal carcinoma
    • Breast cancer
    Investigated Drugs:
    • Nelarabine
    The Netherlands

  • Study on the Effect of Nivolumab and Melphalan in Patients with In-Transit Melanoma Metastases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Nivolumab
    • Sodium Chloride
    The Netherlands Sweden

  • Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

    Recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    Germany

  • Study on Reducing Bleomycin Dose in Electrochemotherapy for Patients with Skin Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Bleomycin
    Denmark

  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Mb-Cart20.1
    • Autologous T-Cells Transduced With Lentiviral Vector Expressing A Chimeric Antigen Receptor Directed Against Cd19
    • Zamtocabtagene Autoleucel
    Germany

  • Study on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Aldesleukin
    • Lifileucel
    • Mesna
    Belgium Czechia Finland France Germany Greece +6
Previous Page
1 2 3 4 5 6 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!